Safety of fluoxetine during the first trimester of pregnancy: A meta-analytical review of epidemiological studies

Psychological Medicine

Volumn 30, Issue 1, 2000, Pages 89-94

  Addis, Antonio ^a   Koren, Gideon ^b  

^a Lab for Mother and Child Health   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE;

ADULT; ARTICLE; CONGENITAL DISORDER; CONTROLLED STUDY; DATA BASE; DEPRESSION; DRUG SAFETY; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL LITERATURE; RISK ASSESSMENT; TERATOGENESIS;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; EPIDEMIOLOGIC STUDIES; FEMALE; FLUOXETINE; HUMANS; INCIDENCE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, FIRST; RISK ASSESSMENT;

EID: 0033951163     PISSN: 00332917     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0033291799001270     Document Type: Article

References (39)

1. Altshuler, L. L. & Szuba, M. P. (1994). Course of psychiatric disorders in pregnancy: Dilemmas in pharmacologic management Neurologic Clinics 12, 613-35.
2. Altshuler, L. L., Cohen, L. Szuba, M. P., Burt, V. K., Gitlin, M. & Mintz, J. (1996). Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. American Journal Psychiatry 153, 492-606.
3. Anonymous (1993). Depression in women: ACOG technical bulletin number 182 July 1993. International Journal of Gynaecology and Obstetrics 43, 203-211.
4. Brunel, P., Vial, T., Roche, I., Bertolotii, E. & Evreux, J. C. (1994). First-trimester exposure to antidepressant drugs. Result of a follow-up. Therapie 49, 117-122.
5. Chambers, C. D., Johnson, K. A. & Jones, K. L. (1993). Pregnancy outcome in women exposed to fluoxetine. Teratology 47, 386.
6. Chambers, C. R., Johnson, K. A., Dick, L. M., Felix, R. J. & Jones, K. L. (1996). Birth outcomes in pregnant women taking fluoxetine. New England Journal of Medicine 335, 1010-1015
7. Cooper, G. L (1988). The safety of fluoxetine: an update British Journal of Psychiatry 3, 77-86.
8. De Cuypere, G., Rombaut, P. & Van Moffaert, M. (1992) Congenital malformations caused by psychotropic drugs in pregnancy. Acta Neuropsychiatrica 4, 77-85.
9. Der Simonian, R. & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials 7, 177-188.
10. Edwards, J. G (1994). Selective serotonin reuptake inhibitors in the treatment of depression. Prescribers' Journal 34, 197-204.
11. Edwards, J G., Inman, W. H., Wilton, L. & Pearce, G. L. (1994). Prescription-event monitoring of 10,401 patients treated with fluvoxamine. British Journal of Psychiatry 164, 387-395.
12. Einarson, T. R., Leeder, S. T. & Koren, G. (1988). A method for meta-analysis of epidemiological studies. Drug Intelligent Clinical Pharmacology 22, 813-824.
13. Franko, D. & Hilsinger, E. (1995). Depression and bulimia in a pregnant woman. Harvard Review of Psychiatry 2, 282-287.
14. Goldstein, D. J. (1995). Effect of third trimester fiuoxetine exposure on the newborn. Journal of Clinical Psychopharmacology 15, 417-420.
15. Goldstein, D. J. & Marvel, D. E. (1993). Psychotropic medication during pregnancy: risk to the fetus. Journal of American Medical Association 270, 2177.
16. Kacew, S. (1994). Fetal consequences and risks attributed to the use of prescribed and over-the-counter (OTC) preparations during pregnancy. International Journal of Clinical Pharmacology and Therapeutics 32, 335-343.
17. Kessler, R. C., McGonagle, K. A., Swartz, M., Blazer, D. G. & Nelson, C. B. (1993). Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. Journal of Affective Disorders 29, 85-96.
18. Koren, G., Bologa, M., Long, D., Feldman, Y. & Shear, N. (1989). Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester. American Journal of Obstetric and Gynecology 160, 1190-1194.
19. Lee, A. & Donaldson, S. (1995). Drug use in pregnancy: psychiatric and neurological disorders Part 1. Pharmaceutical Journal 254, 87-90.
20. Livingston, J. C., Johnstone, W. M. & Hadi, H. A. (1994). Electroconvulsive therapy in a twin pregnancy: a case report. American Journal of Perinatology 11, 116-118.
21. McElhatton, P. R., Garbis, H, M., Elefant, E., Vial, T., Bellemin, B., Mastroiacovo, P., Arnon, J., Rodriguez-Pinilla, E., Schaefer, C., Pexieder, T., Merlob, P. & Dal Verme, S. (1996). The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS). Reproductive Toxicology 10, 285-294.
22. Matthews, D. A., Manu, P. & Lane, T. J. (1991). Evaluation and management of patients with chronic fatigue. American Journal Medical Science 302, 269-277.
23. Miller, L. J. (1996). Psychopharmacology during pregnancy. Primary Care Update for Obstetric Gynecology 3, 79-86.
24. Mortola, J. F. (1994). A risk-benefit appraisal of drugs used in the management of premenstrual syndrome. Drug Safety 10, 160-169.
25. Nightingale, S. L. (1994). Fluoxetine labeling revised to identify phenytoin interaction and to recommend against use in nursing mothers. Journal of American Medical Association 271, 1067.
26. Nulman, I. & Koren, G. (1996). The safety of fluoxetine during pregnancy and lactation. Teratology 53, 304-308.
27. Nulman, I., Rovet, J., Stewart, D. E., Wolpin, J., Gaudner, A., Theis, J. G. W. Kullin, N. & Koren, G. (1997). Neurodevelopment of children exposed in utero to antidepressant drugs. New England Journal of Medicine 336, 258-262.
28. Pastuszak, A., Schick-Boschetto, B., Zuber, C., Feldkamp, M., Pinelli, M., Sihn, S., Donnenfeld, A., McCormack, M., Leen-Mitchell, M., Woodland, C., Gardner, A., Horn, M. & Koren, G. (1993). Pregnancy outcome following first-trimester exposure to fluoxetine. Journal of American Medical Association 269, 2246-2248.
29. Rand, E. H. (1991). Choosing an antidepressant to treat depression. American Family Physician 43, 847-854.
30. Rosa, F. (1994) Medicaid antidepressant pregnancy exposure outcomes. Reproductive Toxicology 8, 444-445.
31. Schick-Boschetto, B. & Zuber, C. (1992). Fluoxetine exposure in early human pregnancy. Teratology 45, 460.
32. Schorr, S. J. & Richardson. D. (1995). Psychiatric emergencies. Obstetric Gynecological Clinics of North American 22, 369-383.
33. Schwartz, J. T. & Brotman, A. W. (1992). A clinical guide to antipsychotic drugs. Drugs 44, 981-992.
34. Sichel, D. A., Cohen, L. S., Dimmock, J. A. & Rosenbaum, J. F. (1993). Postpartum obsessive compulsive disorder: a case series. Journal of Clinical Psychiatry 54, 156-159.
35. Skrabanek, P. (1992). Smoking and statistical overkill. Lancet 340, 1208-1209.
36. Spencer, M. J. (1993). Fluoxetine hydrochloride (Prozac) toxicity in a neonate. Pediatrics 92, 721-722.
37. Stevenson, R. E. (1993). Causes of human anomalies: an overview and historical perspective. In Human Malformations and Related Anomalies (ed. R. E. Stevenson), pp. 3-20. Oxford University Press: New York
38. Vendittelli, F., Alain, J., Nouvaille, Y., Brosset, A. & Tabaste, J. L. (1995). A case of lipomeningocele reported with fluoxetine (and alprazolam, vitamins B1 and B6, heptaminol) prescribed during pregnancy. European Journal of Obstetrics, Gynecology and Reproductive Biology 38, 85-86.
39. Weissman, M. M., Bruce, M. L., Leaf, P. I., Florio, L. P. & Holzer, C. III (1991). Affective disorders. In Psychiatric Disorders in America (ed. N. Robins and D. Reiger), pp. 53-80. Free Press: New York.